Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.
During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes can cause gastroparesis due to its effects on the nervous system.
Both type 1 diabetes and type 2 diabetes can cause nerve damage. One of the nerves diabetes may damage is the vagus nerve. The vagus nerve controls the movement of food through the stomach. When the vagus nerve experiences damage, the muscles in the stomach and other parts of the digestive tract are not able to function properly. When this happens, food cannot move as quickly through the digestive system. Gastroparesis is also known as delayed gastric emptying.
The global Diabetic Gastroparesis Treatment revenue was US$ 3398.3 million in 2022 and is forecast to a readjusted size of US$ 5100.2 million by 2029 with a CAGR of 5.9% during the review period (2023-2029).
In India, the Diabetic Gastroparesis Treatment revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
Market is not concentrated. Sumitomo, Johnson & Johnson, Sanofi are the leaders of the industry, and hold the key technologies and patent, with high-end customers. Top 3 manufacturer accounted for 7.4% market share in 2019.
This report focuses on global and India Diabetic Gastroparesis Treatment market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Diabetic Gastroparesis Treatment will continue to grow rapidly in the future.
Global Diabetic Gastroparesis Treatment Scope and Market Size
Diabetic Gastroparesis Treatment market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Diabetic Gastroparesis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Diabetic Gastroparesis Treatment market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.
Surgical Treatment Products
Chapter 1: Introduces Diabetic Gastroparesis Treatment definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Diabetic Gastroparesis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5: Revenue of Diabetic Gastroparesis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by type, by application and by country revenue for each segment.
Chapter 7: EMEA by type, by application and by region, revenue for each segment.
Chapter 8: China by type, by application revenue for each segment.
Chapter 9: APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Gastroparesis Treatment revenue, gross margin and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusions